Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,213 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mesothelin targeted cancer immunotherapy.
Hassan R, Ho M. Hassan R, et al. Among authors: ho m. Eur J Cancer. 2008 Jan;44(1):46-53. doi: 10.1016/j.ejca.2007.08.028. Epub 2007 Oct 22. Eur J Cancer. 2008. PMID: 17945478 Free PMC article. Review.
Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients.
Ho M, Hassan R, Zhang J, Wang QC, Onda M, Bera T, Pastan I. Ho M, et al. Clin Cancer Res. 2005 May 15;11(10):3814-20. doi: 10.1158/1078-0432.CCR-04-2304. Clin Cancer Res. 2005. PMID: 15897581
Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapy.
Nagata S, Ise T, Onda M, Nakamura K, Ho M, Raubitschek A, Pastan IH. Nagata S, et al. Among authors: ho m. Proc Natl Acad Sci U S A. 2005 May 31;102(22):7946-51. doi: 10.1073/pnas.0502975102. Epub 2005 May 19. Proc Natl Acad Sci U S A. 2005. PMID: 15905329 Free PMC article.
New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA.
Onda M, Willingham M, Nagata S, Bera TK, Beers R, Ho M, Hassan R, Kreitman RJ, Pastan I. Onda M, et al. Among authors: ho m. Clin Cancer Res. 2005 Aug 15;11(16):5840-6. doi: 10.1158/1078-0432.CCR-05-0578. Clin Cancer Res. 2005. PMID: 16115924
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
Yokokawa J, Palena C, Arlen P, Hassan R, Ho M, Pastan I, Schlom J, Tsang KY. Yokokawa J, et al. Among authors: ho m. Clin Cancer Res. 2005 Sep 1;11(17):6342-51. doi: 10.1158/1078-0432.CCR-05-0596. Clin Cancer Res. 2005. PMID: 16144939 Free PMC article.
Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma.
Onda M, Nagata S, Ho M, Bera TK, Hassan R, Alexander RH, Pastan I. Onda M, et al. Among authors: ho m. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4225-31. doi: 10.1158/1078-0432.CCR-06-0472. Clin Cancer Res. 2006. PMID: 16857795
Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice.
Zhang Y, Xiang L, Hassan R, Paik CH, Carrasquillo JA, Jang BS, Le N, Ho M, Pastan I. Zhang Y, et al. Among authors: ho m. Clin Cancer Res. 2006 Aug 1;12(15):4695-701. doi: 10.1158/1078-0432.CCR-06-0346. Clin Cancer Res. 2006. PMID: 16899620
Mesothelin is shed from tumor cells.
Ho M, Onda M, Wang QC, Hassan R, Pastan I, Lively MO. Ho M, et al. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1751. doi: 10.1158/1055-9965.EPI-06-0479. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16985043 No abstract available.
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.
Gubbels JA, Belisle J, Onda M, Rancourt C, Migneault M, Ho M, Bera TK, Connor J, Sathyanarayana BK, Lee B, Pastan I, Patankar MS. Gubbels JA, et al. Among authors: ho m. Mol Cancer. 2006 Oct 26;5(1):50. doi: 10.1186/1476-4598-5-50. Mol Cancer. 2006. PMID: 17067392 Free PMC article.
Mesothelin expression in human lung cancer.
Ho M, Bera TK, Willingham MC, Onda M, Hassan R, FitzGerald D, Pastan I. Ho M, et al. Clin Cancer Res. 2007 Mar 1;13(5):1571-5. doi: 10.1158/1078-0432.CCR-06-2161. Clin Cancer Res. 2007. PMID: 17332303
3,213 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback